Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06123143 · ClinicalTrials.gov registry record · NA

Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants

A NA study of Neonatal Respiratory Failure, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
130
Enrollment target
5
Study locations

NCT06123143 is a NA study of Neonatal Respiratory Failure that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 130 participants. The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06123143, a NA study of Neonatal Respiratory Failure, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
5
Study locations

Study Summary

Preterm neonates born at less than 30 weeks' gestation are commonly maintained on invasive or non-invasive respiratory support to facilitate gas exchange. While non-invasive respiratory support (NIS) can be gradually reduced over time as the infant grows, most weaning strategies often lead to weaning failure. This failure is evidenced by an increase in significant events such as apneas, desaturations, and/or bradycardias, increased work of breathing, or an inability to oxygenate or ventilate, resulting in escalated respiratory support. Although the optimal approach to weaning NIS remains uncertain, neonatal units that delay Continuous Positive Airway Pressure (CPAP) weaning until 32-34 weeks corrected gestational age exhibit lower rates of chronic lung disease. Therefore, the investigators aim to compare the duration on respiratory support and oxygen exposure in infants born at less than 30 weeks' gestational age who undergo a structured weaning protocol that includes remaining on CPAP until at least 32-34 weeks corrected gestational age (CGA). The hypothesis posits that preterm infants following a structured weaning protocol, including maintaining CPAP until a specific gestational age, will demonstrate lower rates of weaning failure off CPAP (defined as requiring more support and/or experiencing increased stimulation events 72 hours after CPAP weaning) than those managed according to the medical team's discretion.

Interventions

  • OTHER Standardized/structured CPAP weaning protocol

Study Locations (5)

California

  • Palomar Medical Center Rady NICU - Escondido
  • Scripps La Jolla Rady NICU - La Jolla
  • University of California, San Diego Jacobs Medical Center - La Jolla
  • Rancho Springs Medical Center Rady NICU - Murrieta
  • Rady Children's Hospital-San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2023-11-27
Est. Completion 2028-11
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT06123143

The ClinicalTrials.gov registry entry for NCT06123143 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neonatal Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Standardized/structured CPAP weaning protocol is the first listed.

NCT06123143 reports 5 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06123143 about?

NCT06123143 is a clinical study titled "Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants". Preterm neonates born at less than 30 weeks' gestation are commonly maintained on invasive or non-invasive respiratory support to facilitate gas exchange. While non-invasive respiratory support (NIS) can be gradually reduced over time as the infant grows, most weaning strategies often lead to weanin...

What is the current status of trial NCT06123143?

This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2023-11-27. Estimated completion is 2028-11.

What conditions does trial NCT06123143 study?

This clinical trial studies the following conditions: Neonatal Respiratory Failure.

What interventions are being tested in trial NCT06123143?

The interventions under investigation include: Standardized/structured CPAP weaning protocol (OTHER).

Who is sponsoring clinical trial NCT06123143?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06123143 being conducted?

This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neonatal Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.